Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-4_09-cv-04157/USCOURTS-cand-4_09-cv-04157-3/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Personal Injury

---

Judge Miller took no part in the decision of this matter. *

UNITED STATES JUDICIAL PANEL

on

MULTIDISTRICT LITIGATION

IN RE: SEROQUEL PRODUCTS LIABILITY LITIGATION MDL No. 1769

ORDER DENYING MOTION FOR RECONSIDERATION

Before the entire Panel : Defendants AstraZeneca Pharmaceuticals LP and AstraZeneca LP *

move the Panel to reconsider its order filed on February 5, 2010, which denied transfer of the fifteen

Northern District of California actions listed on Schedule A. Defendants urge the Panel to transfer the

actions to the Middle District of Florida for inclusion in MDL No. 1769. Plaintiffs in the fifteen actions

oppose the motion and continue to object to transfer of their actions. 

After considering all argument of counsel, we find that the moving defendants have not

presented any circumstances that justify reconsideration of the Panel’s order. The Panel was aware of

the arguments of the parties as well as the status of the proceedings in the transferee court when it

rendered its decision.

IT IS THEREFORE ORDERED that the motion for reconsideration is denied.

PANEL ON MULTIDISTRICT LITIGATION

_________________________________________

 John G. Heyburn II 

 Chairman

Robert L. Miller, Jr. Kathryn H. Vratil *

David R. Hansen W. Royal Furgeson, Jr.

Frank C. Damrell, Jr.

Case 4:09-cv-04157-CW Document 31 Filed 05/06/10 Page 1 of 2
IN RE: SEROQUEL PRODUCTS LIABILITY LITIGATION MDL No. 1769 

SCHEDULE A 

Northern District of California

Lisa Bain, et al. v. AstraZeneca LP, et al., C.A. No. 3:09-4147 

Donald Bates, Jr., et al. v. AstraZeneca LP, et al., C.A. No. 3:09-4150 

Carolyn Harrison, et al. v. AstraZeneca LP, et al., C.A. No. 3:09-4151 

Cynthia Arnold, et al. v. AstraZeneca LP, et al., C.A. No. 3:09-4157 

Todd Boggis, et al. v. AstraZeneca LP, et al., C.A. No. 3:09-4159 

Paul Trim, et al. v. AstraZeneca LP, et al., C.A. No. 3:09-4160 

Mark Coffey, et al. v. AstraZeneca LP, et al., C.A. No. 3:09-4161 

Gloria Miller, et al. v. AstraZeneca LP, et al., C.A. No. 3:09-4163 

Sharon Diston, et al. v. AstraZeneca LP, et al., C.A. No. 3:09-4165 

Lisa Saunders, et al. v. AstraZeneca LP, et al., C.A. No. 4:09-4148 

Kimberly Kessler, et al. v. AstraZeneca LP, et al., C.A. No. 4:09-4149 

Angel Colon, et al. v. AstraZeneca LP, et al., C.A. No. 4:09-4158 

Antonio Burton, et al. v. AstraZeneca LP, et al., C.A. No. 4:09-4162 

David Marte, et al. v. AstraZeneca LP, et al., C.A. No. 4:09-4164 

Bong Nguygen, et al. v. AstraZeneca LP, et al., C.A. No. 4:09-4166 

Case 4:09-cv-04157-CW Document 31 Filed 05/06/10 Page 2 of 2